Journal of Pineal Research · 1998 · 126 citations · 12 references
MedicineNeurosciencePharmacologyNeurochemistryNeuropharmacologyPsychopharmacologyGlutamatergic PharmacologyNeurochemical PharmacologyNeuroprotectionAnticonvulsant ActionAnticonvulsant DrugsAnticonvulsant PharmacologyAnticonvulsant TreatmentGlutamate AntagonistsMelatonin PharmacologyMelatonin TreatmentSeizures
Melatonin was tested in an ongoing attempt to find the endogenous antagonists of quinolinic acid, an endogenous convulsant. Among a great number of metabolites that have been tried before, only a few were found (cerulein and quinaldic acid in mice and kynurenic acid in rats). In SHR (bred from Swiss) male mice, intracerebroventricular (i.c.v.) pretreatment with melatonin (1.25-10.0 microg) attenuated (in the descending order of potency) the convulsant effect of i.c.v. administered kainate, quinolinate, glutamate, N-methyl-D-aspartate, and pentylenetetrazole. Melatonin was ineffective against i.p. administered pentylenetetrazole. Systemically (intraperitoneal, i.p.) administered melatonin (12.5-100.0 mg/kg) attenuated the convulsant effect of quinolinate, while the action of other convulsants used remained unaltered. It is suggested that melatonin could be tried against grand mal seizures in epileptic patients.
12
Genetic Control of Melatonin Synthesis in the Pineal Gland of the Mouse
Shizufumi Ebihara, Theodore Marks, David J. Hudson et al. · Science · 1986 · 356 citations
Medicine, Endocrinology, Genetics +17
Melatonin Content of the Pineal Gland in Different Mouse Strains
Maki Goto, I Oshima, Takeshi Tomita et al. · Journal of Pineal Research · 1989 · 281 citations
I. P. Lapin · Epilepsia · 1981 · 154 citations